These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The effect of N-methyl-2-pyridone-5-carboxamide--A nicotinamide catabolite on poly ADP-rybosylation and oxidative stress injury in endothelial cells. Slominska EM; Smolenski RT; Osborne F; Swierczynski J; Yacoub MH Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):259-62. PubMed ID: 16021911 [TBL] [Abstract][Full Text] [Related]
8. N-methyl-2-pyridone-5-carboxamide (N-Me-2PY) has potent anti-fibrotic and anti-inflammatory activity in a fibrotic kidney model: is it an old uremic toxin? Yoshimura N; Yamada K; Ono T; Notoya M; Yukioka H; Takahashi R; Wakino S; Kanda T; Itoh H Clin Exp Nephrol; 2023 Nov; 27(11):901-911. PubMed ID: 37490135 [TBL] [Abstract][Full Text] [Related]
9. Urinary Excretion of Deen CPJ; van der Veen A; Gomes-Neto AW; Geleijnse JM; Borgonjen-van den Berg KJ; Heiner-Fokkema MR; Kema IP; Bakker SJL J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32041099 [No Abstract] [Full Text] [Related]
10. 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues? Synesiou E; Fairbanks LD; Simmonds HA; Slominska EM; Smolenski RT; Carrey EA Toxins (Basel); 2011 Jun; 3(6):520-37. PubMed ID: 22069723 [TBL] [Abstract][Full Text] [Related]
11. Distribution of purine nucleotides in uremic fluids and tissues. Rutkowski B; Rutkowski P; Słomińska E; Swierczyński J J Ren Nutr; 2010 Sep; 20(5 Suppl):S7-10. PubMed ID: 20797575 [TBL] [Abstract][Full Text] [Related]
12. Relationship between uremic toxins and oxidative stress in patients with chronic renal failure. Rutkowski P; Słominska EM; Szołkiewicz M; Aleksandrowicz E; Smolenski RT; Wołyniec W; Renke M; Wisterowicz K; Swierczynski J; Rutkowski B Scand J Urol Nephrol; 2007; 41(3):243-8. PubMed ID: 17469035 [TBL] [Abstract][Full Text] [Related]
14. Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation. Menon RM; Adams MH; González MA; Tolbert DS; Leu JH; Cefali EA Int J Clin Pharmacol Ther; 2007 Aug; 45(8):448-54. PubMed ID: 17725178 [TBL] [Abstract][Full Text] [Related]
15. Origin and characteristics of an unusual pyridine nucleotide accumulating in erythrocytes: positive correlation with degree of renal failure. Carrey EA; Smolenski RT; Edbury SM; Laurence A; Marinaki AM; Duley JA; Zhu L; Goldsmith DJ; Simmonds HA Clin Chim Acta; 2003 Sep; 335(1-2):117-29. PubMed ID: 12927693 [TBL] [Abstract][Full Text] [Related]
16. Oxalic Acid as a uremic toxin. Mydlík M; Derzsiová K J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441 [TBL] [Abstract][Full Text] [Related]
17. High plasma adenine concentration in chronic renal failure and its relation to erythrocyte ATP. Slominska EM; Szolkiewicz M; Smolenski RT; Rutkowski B; Swierczynski J Nephron; 2002 Jun; 91(2):286-91. PubMed ID: 12053067 [TBL] [Abstract][Full Text] [Related]
18. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. Hasegawa K; Matsushita Y; Inoue T; Morii H; Ishibashi M; Yamaji T J Clin Endocrinol Metab; 1986 Oct; 63(4):819-22. PubMed ID: 2943754 [TBL] [Abstract][Full Text] [Related]